Lauren Silverman is a Managing Director at Novartis, whose known portfolio counts 16 companies.
Is Lauren Silverman a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCell & Gene TherapyDiagnosticsDrug DiscoveryGenomicsImmunologyMedTechOncologyPharma
Contacts
Affiliated funds' portfolios
Managing Director at Novartis, whose known portfolio counts 16 companies
- Octave
- Vor Biopharma
- Patientory
- Orna Therapeutics
- Pliant Therapeutics
- TScan Therapeutics
- CatalYm
- Dren Bio
- Surface Oncology
- Cadent Therapeutics
- Flare Therapeutics
- Medtech Africa
- and 4 more
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Cell & Gene Therapy, Diagnostics and Drug Discovery fall inside that listing.
Stage-wise, the deals at Novartis cluster around Growth, Seed and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether Lauren Silverman is worth approaching.
Colleagues at Novartis
Paolo Malerba
Strategy Lead
London, United Kingdom
Jose Marcilla
President Latin America and Canada (LACan) Region
United States
Beat Steffen
Managing Director Novartis Venture Fund
Basel, Switzerland
Marianne Uteng
Managing Director
Basel, Switzerland
Anja König
Global Head Novartis Venture Fund
Basel, Switzerland
Jason Freeman
Senior Medical Director
Washington, United States
Shejoy Varghese
Managing partner
Ernakulam, India
Marc Ceulemans
Head, Strategic Venture Capital Fund
Laax, Switzerland
Md. Sohel Rana
Managing Partner
Bangladesh
Steven Breazzano
Investor
Fairfield, United States
Stefanie D.
Portfolio Reporting Director
Zürich, Switzerland
Frequently asked questions
Who is Lauren Silverman?
Lauren Silverman is a corporate venture investor based in Cambridge, Massachusetts, United States, listed as Managing Director at Novartis. The known portfolio of that firm counts 16 companies. That portfolio belongs to the firm, not to Lauren Silverman personally.
What does Lauren Silverman invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell & Gene Therapy, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Lauren Silverman invest at?
Novartis appears in Growth, Seed and Series A rounds across its known deals, and Lauren Silverman is listed there as Managing Director. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Lauren Silverman listed at?
Lauren Silverman is listed as Managing Director at Novartis. 11 other people in the database share a firm with Lauren Silverman.
How do I contact Lauren Silverman?
A LinkedIn page is on file for Lauren Silverman. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal